SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $44,668,600 | +1254.3% | 368,492 | +1179.5% | 1.06% | +1375.0% |
Q2 2023 | $3,298,176 | -86.1% | 28,800 | -83.2% | 0.07% | -85.2% |
Q1 2023 | $23,660,311 | +3854.8% | 171,663 | +3618.1% | 0.48% | +3364.3% |
Q4 2022 | $598,271 | -62.8% | 4,617 | -68.3% | 0.01% | -65.0% |
Q3 2022 | $1,609,000 | +35.1% | 14,561 | -8.4% | 0.04% | +29.0% |
Q2 2022 | $1,191,000 | -69.2% | 15,890 | -63.0% | 0.03% | -65.9% |
Q4 2021 | $3,872,000 | +16.3% | 43,000 | +19.4% | 0.09% | -1.1% |
Q3 2021 | $3,329,000 | +665.3% | 36,000 | +542.9% | 0.09% | +557.1% |
Q2 2021 | $435,000 | +86.7% | 5,600 | +186.0% | 0.01% | -39.1% |
Q1 2019 | $233,000 | -77.7% | 1,958 | -93.7% | 0.02% | -89.4% |
Q2 2017 | $1,045,000 | -3.5% | 31,000 | -15.3% | 0.22% | +7.4% |
Q1 2017 | $1,083,000 | +286.8% | 36,600 | +258.8% | 0.20% | +215.6% |
Q4 2016 | $280,000 | -41.8% | 10,200 | +30.3% | 0.06% | -38.5% |
Q3 2016 | $481,000 | -49.0% | 7,830 | -83.8% | 0.10% | -71.2% |
Q1 2016 | $943,000 | – | 48,300 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |